Novel MiRNA-mRNA Interactions Conserved in Essential Cancer Pathways

Overview

Journal Sci Rep

Specialty Science

Date 2017 Apr 8

PMID 28387377

Citations 20

Authors

Eduardo Andres-Leon

Ildefonso Cases

Sergio Alonso

Ana M Rojas

Affiliations

Soon will be listed here.

Abstract

Cancer is a complex disease in which unrestrained cell proliferation results in tumour development. Extensive research into the molecular mechanisms underlying tumorigenesis has led to the characterization of oncogenes and tumour suppressors that are key elements in cancer growth and progression, as well as that of other important elements like microRNAs. These genes and miRNAs appear to be constitutively deregulated in cancer. To identify signatures of miRNA-mRNA interactions potentially conserved in essential cancer pathways, we have conducted an integrative analysis of transcriptomic data, also taking into account methylation and copy number alterations. We analysed 18,605 raw transcriptome samples from The Cancer Genome Atlas covering 15 of the most common types of human tumours. From this global transcriptome study, we recovered known cancer-associated miRNA-targets and importantly, we identified new potential targets from miRNA families, also analysing the phenotypic outcomes of these genes/mRNAs in terms of survival. Further analyses could lead to novel approaches in cancer therapy.

Citing Articles

Combination of miR-99b-5p and Enzalutamide or Abiraterone Synergizes the Suppression of EMT-Mediated Metastasis in Prostate Cancer.

Waseem M, Wang B Cancers (Basel). 2024; 16(10).

PMID: 38792011 PMC: 11119738. DOI: 10.3390/cancers16101933.

Tumor suppressive miR-99b-5p as an epigenomic regulator mediating mTOR/AR/SMARCD1 signaling axis in aggressive prostate cancer.

Waseem M, Gujrati H, Wang B Front Oncol. 2023; 13:1184186.

PMID: 38023145 PMC: 10661933. DOI: 10.3389/fonc.2023.1184186.

Major regulators of the multi-step metastatic process are potential therapeutic targets for breast cancer management.

de Azevedo A, Mingorance Carvalho T, Mara C, Giner I, de Oliveira J, Gradia D Funct Integr Genomics. 2023; 23(2):171.

PMID: 37211553 DOI: 10.1007/s10142-023-01097-x.

Downregulation of miR-99b-5p and Upregulation of Nuclear mTOR Cooperatively Promotes the Tumor Aggressiveness and Drug Resistance in African American Prostate Cancer.

Gujrati H, Ha S, Waseem M, Wang B Int J Mol Sci. 2022; 23(17).

PMID: 36077039 PMC: 9455949. DOI: 10.3390/ijms23179643.

Role of transcribed ultraconserved regions in gastric cancer and therapeutic perspectives.

Gao S, Zhang Z, Wang X, Ma Y, Yin G, Guo X World J Gastroenterol. 2022; 28(25):2900-2909.

PMID: 35978878 PMC: 9280734. DOI: 10.3748/wjg.v28.i25.2900.

References

Helwak A, Kudla G, Dudnakova T, Tollervey D . Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013; 153(3):654-65. PMC: 3650559. DOI: 10.1016/j.cell.2013.03.043. View

Forbes S, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H . COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2014; 43(Database issue):D805-11. PMC: 4383913. DOI: 10.1093/nar/gku1075. View

Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

Diez-Villanueva A, Mallona I, Peinado M . Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer. Epigenetics Chromatin. 2015; 8:22. PMC: 4480445. DOI: 10.1186/s13072-015-0014-8. View

Andres-Leon E, Gonzalez Pena D, Gomez-Lopez G, Pisano D . miRGate: a curated database of human, mouse and rat miRNA-mRNA targets. Database (Oxford). 2015; 2015:bav035. PMC: 4390609. DOI: 10.1093/database/bav035. View

Zhang Y, Wen X, Hu X, Cheng L, Yu J, Wei Z . Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer. Eur Rev Med Pharmacol Sci. 2016; 20(14):3026-30. View

Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D . Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009; 24(4):652-7. DOI: 10.1111/j.1440-1746.2008.05666.x. View

Karra H, Repo H, Ahonen I, Loyttyniemi E, Pitkanen R, Lintunen M . Cdc20 and securin overexpression predict short-term breast cancer survival. Br J Cancer. 2014; 110(12):2905-13. PMC: 4056061. DOI: 10.1038/bjc.2014.252. View

Duan J, Huang W, Shi H . Positive expression of KIF20A indicates poor prognosis of glioma patients. Onco Targets Ther. 2016; 9:6741-6749. PMC: 5098585. DOI: 10.2147/OTT.S115974. View

10.

Lesnock J, Darcy K, Tian C, Deloia J, Thrall M, Zahn C . BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study. Br J Cancer. 2013; 108(6):1231-7. PMC: 3619264. DOI: 10.1038/bjc.2013.70. View

11.

Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

12.

Andres-Leon E, Nunez-Torres R, Rojas A . miARma-Seq: a comprehensive tool for miRNA, mRNA and circRNA analysis. Sci Rep. 2016; 6:25749. PMC: 4863143. DOI: 10.1038/srep25749. View

13.

Lytle J, Yario T, Steitz J . Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A. 2007; 104(23):9667-72. PMC: 1887587. DOI: 10.1073/pnas.0703820104. View

14.

Kim B, Kang S, Han H, Lee J, Kim J, Lee S . Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targets. Oncotarget. 2016; 7(19):27468-78. PMC: 5053664. DOI: 10.18632/oncotarget.8322. View

15.

Arcas A, Fernandez-Capetillo O, Cases I, Rojas A . Emergence and evolutionary analysis of the human DDR network: implications in comparative genomics and downstream analyses. Mol Biol Evol. 2014; 31(4):940-61. PMC: 3969565. DOI: 10.1093/molbev/msu046. View

16.

Wu W, Hu K, Wang D, Zeng Z, Zhang D, Chen D . CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer. J Transl Med. 2013; 11:142. PMC: 3691738. DOI: 10.1186/1479-5876-11-142. View

17.

Yates A, Akanni W, Amode M, Barrell D, Billis K, Carvalho-Silva D . Ensembl 2016. Nucleic Acids Res. 2015; 44(D1):D710-6. PMC: 4702834. DOI: 10.1093/nar/gkv1157. View

18.

Chen G, Hu J, Huang Z, Yang L, Chen M . MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1. Biochem Biophys Res Commun. 2016; 473(4):1144-1151. DOI: 10.1016/j.bbrc.2016.04.030. View

19.

Min H, Yoon S . Got target? Computational methods for microRNA target prediction and their extension. Exp Mol Med. 2010; 42(4):233-44. PMC: 2859323. DOI: 10.3858/emm.2010.42.4.032. View

20.

Jusufovic E, Rijavec M, Keser D, Korosec P, Sodja E, Iljazovic E . let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer. PLoS One. 2012; 7(9):e45577. PMC: 3454421. DOI: 10.1371/journal.pone.0045577. View